Observer-blind Safety and Immunogenicity Study of GlaxoSmithKline Biologicals' Influenza Vaccine GSK2186877A When Administered to Elderly Subjects.
Phase of Trial: Phase III
Latest Information Update: 25 Nov 2016
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 13 Feb 2014 New trial record
- 24 Dec 2012 Status changed from recruiting to active, not recruiting, as reported by ClinicalTrials.gov.
- 13 Jun 2009 Status changed from active, not recruiting to completed, as reported by ClinicalTrials.gov.